MedPath

TO COMPARE THE EFFECT OF ROPIVACAINE & ROPIVACAINE WITH MAGNESIUM SULPHATE AS ADJUVANT IN USG GUIDED FASCIA ILIACA BLOCK FOR PATIENTS UNDERGOING PROXIMAL FEMUR FRACTURE SURGERY

Phase 4
Not yet recruiting
Conditions
Fracture of head and neck of femur, (2) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2023/05/052200
Lead Sponsor
KASTURI DASH
Brief Summary

ROPIVACAINE IS A LONG ACTING LOCAL ANAESTHETIC WITH LESS CARDIOTOXIC AND NEUROTOXIC SIDE EFFECTS AND SPARES THE MOTOR BLOCK AND INCREASES DURATION OF SENSORY BLOCK.SO ADDING ADJUVANT LIKE MAGNESIUM SULPHATE BEING FASTER IN ACTION MAY PRODUCE DENSER BLOCK AND PROLONG THE DURATION OF ANALGESIA

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1.AGE >18YEARS 2.PATIENTS POSTED FOR PROXIMAL FEMUR SURGERY.

Exclusion Criteria

1.ALLERGY 2.PATIENT WITH CHRONIC PAIN SYNDROME 3.ANALGESIC ABUSE 4.ADDICTION TO ALCOHOL/OPIODS 5.COAGULOPATHY 6.INFECTION/SEPSIS AT SITE OF INJECTION 7.SEVERE RENAL FAILURE 8.MYASTHENIA GRAVIS 9.PULMONARY EDEMA 10.HEART BLOCK.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.TIME REQUIRED FOR FIRST ANALGESIC DEMANDFIRST POST OPERATIVE DAY
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KALINGA INSTITUTE OF MEDICAL SCIENCE

🇮🇳

Khordha, ORISSA, India

KALINGA INSTITUTE OF MEDICAL SCIENCE
🇮🇳Khordha, ORISSA, India
KASTURI DASH
Principal investigator
9437007099
titlidash@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.